The 25 Biggest Insider Purchases in October
Insider purchases consistently outpaced insider sales during much of October, the first time that has happened over a minimum two-week period since January...
Posts Tagged ‘Sarepta Therapeutics Inc. (SRPT)’
Here’s How This Week Has Started For The Financial Markets
1. U.S. Stock Market: “U.S. stocks rose on Monday, boosted by technology shares and by defense companies, which rose after the United States and...
Here’s What Is Going On In The Financial Markets Today?
1. US Stock Market: “U.S. stocks traded firmly higher Wednesday, with the Nasdaq Composite setting an intraday record, after a strong reading on...
Why Sarepta Therapeutics Inc (SRPT) Shares Are Surging
Sarepta Therapeutics Inc (NASDAQ:SRPT) shares have popped 4% after Edward Nash of SunTrust upgraded the equity to ‘Buy’ from ‘Hold...
What Do Hedge Funds Think of Sarepta Therapeutics Inc (SRPT)?
In a rather quiet market where the Dow is down but the S&P and NASDAQ are both up, Sarepta Therapeutics Inc (NASDAQ:SRPT) shares have rallied 3%,...
Sarepta Therapeutics Inc (SRPT) Gets Off To A Running Start With Eteplirsen
Sarepta Therapeutics Inc (NASDAQ:SRPT) is one of the week’s biggest winners from the J.P. Morgan healthcare conference, with the company running up...
5 Medical Tech Stocks You Should Be Investing In
The medical sector is growing rapidly and getting in on the ground floor with med tech can be highly profitable for smart investors, but how can you know...
Sarepta Therapeutics Inc. (SRPT) Stock: Jason Karp Is A Shareholder Again And Has A Larger Position Than Ever
Jason Karp‘s Tourbillon Capital Partners has retaken a stake in Sarepta Therapeutics Inc (NASDAQ:SRPT) after having sold off its previous position...
Sarepta Therapeutics Inc (SRPT) Stock: “Eteplirsen Approval Controversy Rages On”
If you follow Sarepta Therapeutics Inc (NASDAQ:SRPT), you know about Eteplirsen. The treatment is designed to treat several diseases, including Duchenne...
Today’s Trending Stocks: Sarepta, Humana, HTG Molecular Diagnostics, and More
After yesterday’s rather sharp fall, Wall Street is quiet today as the Dow is up only 14 points while the NASDAQ is 0.01% in the green. In this...
Why Sarepta Therapeutics, Ralph Lauren, Fifth Third Bancorp, and Two Other Stocks Are in Spotlight on Friday
WTI crude futures have sank below the $50 per barrel mark around noon as traders brace for another potential rise in the rig count. In addition, all three...
Here’s Why These Five Stocks Are in the Spotlight Today
Volatility is low and the markets are quiet today, although three major indexes are trading in the red. In this article, we will analyze five stocks that...
Here’s Why These Five Stocks Are Trading Higher Today
Broad markets are shaky today with NASDAQ trading in red territory. Major indices are oscillating between positive and negative trend on account of Deutsche...
Why Wells Fargo, Sarepta, Delphi, UPS, and More Are Making Headlines
With the U.S. Presidential debate on September 26 expected to draw a massive audience, many traders are eagerly anticipating the latest polling numbers...
Rite Aid Corporation, WCI Communities & Other Stocks in Spotlight Following Earnings, M&A News and More
Wall Street is quiet today after the Federal Reserve’s Wednesday decision of keeping interest rates the same. All three major index futures are...
NASH Hype Has These 2 Stocks Soaring, Plus the Latest On MGT Capital, PTC Therapeutics, and Cloud Peak Energy
There is little fear on the Street today, as all three major indexes are moderately higher. Although the calm mood might change if the Fed announces an...
Sarepta Soars to 150% Q3 Gains, Wal-Mart Closes Jet Deal, SeaWorld Sinks & More
After sharp moves over the past few weeks, investors are collectively calm at the moment as the market awaits the Fed’s decision on whether to...
Sarepta Therapeutics Inc (SRPT), PTC Therapeutics, Inc. (PTCT) and More: Here’s Why These Stocks Are on Investors’ Radars Today
Wall Street is in bull mode today as all three major indexes are in the green, with the Dow rising 90 points, the S&P 500 increasing 0.5% and the...
Why Sarepta, Glu Mobile, Harmony Gold and 2 Other Stocks Are On The Move Today
The markets are mixed on Wednesday as investors remain cautious amid declining crude prices and rising bond yields, which could pressure stocks. Some...
Summit Therapeutics PLC (ADR) (SMMT) Is Hot On Sarepta Therapeutics Inc (SRPT)’s DMD Tail
Duchenne’s Muscular Dystrophy (DMD) is a hot topic right now. The furor surrounding Sarepta Therapeutics Inc (NASDAQ:SRPT)’s Eteplirsen, which just...
Why GE, Yahoo, and 3 Other Stocks Are Trending This Morning
The markets are in the green ahead of Tuesday’s opening bell, with the S&P, Nasdaq, and Dow futures are all in positive territory, as are crude...
Why AMD, Hovnanian, and Three Other Stocks Are Down Today
The markets have been quiet so far today, amid news involving the ADP private payrolls rising by 173,000 for May and OPEC agreeing to maintain the...
Why Facebook, Opower, Genworth, Apollo Education, and Sarepta Are Spiking Today
Even though oil is down on Monday, U.S stocks are up, partly driven by strength in the financial and consumer discretionary sectors. In this article we...
Why Are Investors Piling Into These Surging Stocks?
Although the Dow Jones Index and the S&P 500 are each close to flat for the day, shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Textura Corp...
Why You Should Watch These Five Stocks Today?
Markets opened higher on Tuesday as companies continue to announce quarterly financial results. A Federal Reserve policy meeting is also scheduled to...
Here’s Why These 5 Stocks Are Deep in the Red Today
Although crude futures have rallied to almost break-even and most of the major earnings reports released so far aren’t sharply negative in terms...
Two Healthcare Companies and One Micro-Cap Company Register Strong Insider Buying
Piggybacking insider trading has been a profitable investment strategy over the past several decades or so based on research, though new regulations...
Top Biotech Picks of Best-Performing Hedge Fund of 2015
Bloomberg recently came out with its list of best performing hedge funds of 2015 and the fund that managed to beat all its rivals and emerge at the top...
Four of the Biggest Movers on a Volatile Friday Morning
Market fear just isn’t going away. With S&P futures down by 2% in the pre-market and crude prices breaking below $30 per barrel, Friday looks...
Here’s Why These Five Stocks Are Plunging Today
With markets slightly in the red on Wednesday, a number of stocks stood out as they are plunging in afternoon trading. In this article we will focus...
Breaking Down Steve Cohen’s Four Latest Moves in Sarepta Therapeutics (SRPT), Smith & Wesson (SWHC), More
Steve Cohen‘s Point72 Asset Management has upped its stake in two companies and added two new holdings to its equity portfolio, according to four...
Nektar Therapeutics (NKTR): Insiders Aren’t Crazy About It But Hedge Funds Love It
Is Nektar Therapeutics (NASDAQ:NKTR) a good investment? Now, according to many of your peers, hedge funds are assumed to be useless, outdated investment...
Acorda Therapeutics Inc (ACOR): Insiders Aren’t Crazy About It But Hedge Funds Love It
To many investors, hedge funds are assumed to be bloated, outdated investment tools of a forgotten age. Although there are In excess of 8,000 hedge funds...
Santarus, Inc. (SNTS): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?
What should a smart Santarus, Inc. (NASDAQ:SNTS) investor do? In the financial world, there are a multitude of gauges investors can use to watch publicly...
Hedge Funds Are Selling Sarepta Therapeutics Inc (SRPT)
Is it smart to be bullish on Sarepta Therapeutics Inc (NASDAQ:SRPT)? If you were to ask many of your fellow readers, hedge funds are seen as overrated...
Sarepta Therapeutics Inc (SRPT), GlaxoSmithKline plc (ADR) (GSK): An Edge Emerges in the Race to Treat Muscular Dystrophy
In a previous article, I speculated on the race to develop a Duchenne muscular dystrophy, or DMD, drug and who might win it. It seems now that Sarepta...
GlaxoSmithKline plc (ADR) (GSK), Sarepta Therapeutics Inc (SRPT): Could This DMD Treatment Become a Blockbuster Drug?
Duchenne muscular dystrophy, or DMD, is a muscle-wasting disease caused by a genetic mutation in the dystrophin gene — the largest gene on the X...
ChemoCentryx Inc (CCXI), GlaxoSmithKline plc (ADR) (GSK): Horrendous Health-Care Stocks This Week
While many investors worried about the Nasdaq’s three-hour shutdown this week, shareholders of a few stocks probably wished it wouldn’t have...
What Hedge Funds Think About VIVUS, Inc. (VVUS)
Are you curious what the richest investors think about VIVUS, Inc. (NASDAQ:VVUS)? In the 21st century investor’s toolkit, there are dozens of metrics...
Alexion Pharmaceuticals, Inc. (ALXN), Sarepta Therapeutics Inc (SRPT), Regeneron Pharmaceuticals Inc (REGN): Is There Any Remaining Value in This Industry Leader?
At some point, a company reaches a level of maximum valuation. It doesn’t mean the company becomes bad, but rather all upside is priced in and future...
Sarepta Therapeutics Inc (SRPT), ISIS Pharmaceuticals, Inc. (ISIS): Is Questcor Pharmaceuticals Inc (QCOR) Still Undervalued?
It has been approximately a year since the Citron Research report about Questcor Pharmaceuticals Inc (NASDAQ:QCOR) came out, which caused the stock to...
GlaxoSmithKline plc (ADR) (GSK), Gilead Sciences, Inc. (GILD): Did Sarepta Therapeutics Inc (SRPT) Just Knock Out Its DMD Competitor?
Ignore the bickering between shareholders of Sarepta Therapeutics Inc (NASDAQ:SRPT) and GlaxoSmithKline plc (ADR) (NYSE:GSK) /Prosensa for a moment...
GlaxoSmithKline plc (ADR) (GSK), Sarepta Therapeutics Inc (SRPT): The Good and Bad of a Competitor’s Failure
On the surface, GlaxoSmithKline plc (ADR) (NYSE:GSK)‘s release of phase 2 data on drisapersen looks like good news for Sarepta Therapeutics Inc...
Mylan Inc. (MYL), YY Inc (ADR) (YY): Stocks Near 52-Week Highs Worth Selling
Even with the broad-based S&P 500 retracing for three straight days amid worries that the Federal Reserve may begin paring back its monthly bond-buying...
Regeneron Pharmaceuticals Inc (REGN), Pharmacyclics, Inc. (PCYC): Is There Pipeline Potential in These Biotech Stocks?
It is not uncommon for a biotechnology company to be valued solely on the potential of one drug. For many small and midcap biotechs, the potential of...
GT Advanced Technologies Inc (GTAT), Outerwall Inc (OUTR): The Nasdaq’s 5 Most Hated Stocks
Economic problems and worries? We’ll have none of those here, says the Nasdaq Composite, which soared to a fresh 12-year high on this week’...
Questcor Pharmaceuticals Inc (QCOR), Sarepta Therapeutics Inc (SRPT): Here’s What This $7 Billion Contrarian Has Been Buying
Every quarter, many money managers have to disclose what they’ve bought and sold, via “13F” filings. Their latest moves can shine a...
AcelRx Pharmaceuticals Inc (ACRX): Long-Term Growth With Biotech Innovators
The global biotechnology industry is expected to reach $320 billion by 2015, up from $232 billion in 2012. Improving healthcare infrastructure and focus...
Sequenom, Inc. (SQNM), Synta Pharmaceuticals Corp. (SNTA): Three Horrendous Health-Care Stocks This Week
This week’s list of the most horrendous health-care stocks is brought to you by the letter “S.” Just like on Sesame Street, all of the...
Array Biopharma Inc (ARRY), InterMune Inc (ITMN): Three Humongous Health-Care Stocks This Week
After extensive research, number-crunching, sorting, and filtering, the results are in. Here are your three most humongous performers in the world of...
